Table 1.
Medication | Percentage (approximate) of people who lose at least 5% of their body weight* | Adverse effects | Comments |
---|---|---|---|
Lorcaserin | 50% | Headache, dizziness | Risk of serotonin syndrome |
Qsymia | 70% with high dose combination | Dry mouth, paresthesia | contraindicated in people with glaucoma, hyperthyroidism, unstable heart disease |
Orlistat | 50% | Flatulence, Vitamin deficiencies | Replace fat soluble vitamins |
Metformin | 50% | GI disturbance, diarrhea | Risk of lactic acidosis |
Exenatide | 50% | Nausea, vomiting | Risk of pancreatitis |
Liraglutide | 76% with 3 mg dose | Nausea, vomiting | Contraindicated if history or family history of Medullary thyroid carcinoma |
Efficacy of some of these medications was evaluated in small studies with significant limitations (e.g. lack of gender, ethnic and racial diversity). The results might not be applicable to general population.